SYNOVEX H DIN 00262064
Health Canada record
| Active ingredient(s) | TESTOSTERONE PROPIONATE 200 MG; ESTRADIOL BENZOATE 20 MG |
|---|---|
| Dosage form | Implant |
| Route | Subcutaneous |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1973 |
| Current status date | 06-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TESTOSTERONE PROPIONATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02245746 | COMPONENT E-H IMPLANTS WITH TYLAN | ELANCO CANADA LIMITED | Implant | TESTOSTERONE PROPIONATE 200 MG; ESTRADIOL BENZOATE 20 MG; TYLOSIN TARTRATE 29 MG | Marketed |
| 01936158 | ANATEST | VETOQUINOL N A INC | Solution | TESTOSTERONE PROPIONATE 100 MG | Cancelled Post Market |
| 01968327 | COMPONENT E-H IMPLANTS | ELANCO CANADA LIMITED | Implant | TESTOSTERONE PROPIONATE 200 MG; ESTRADIOL BENZOATE 20 MG | Dormant |
| 02027062 | MALOGEN IN OIL LIQ 100MG/ML | GERMIPHENE CORPORATION | Liquid | TESTOSTERONE PROPIONATE 100 MG | Cancelled Post Market |
| 00716944 | TESTOSTERONE PROPIONATE INJ 100MG/ML | TARO PHARMACEUTICALS INC | Liquid | TESTOSTERONE PROPIONATE 100 MG | Cancelled Post Market |
| 00401595 | TESTOSTERONE PROPIONATE INJ 100MG/ML | DOMINION VETERINARY LABORATORIES LTD. | Solution | TESTOSTERONE PROPIONATE 100 MG | Dormant |
| 01977571 | TESTOSTERONE PROPIONATE INJECTION, USP | STERIMAX INC | Liquid | TESTOSTERONE PROPIONATE 100 MG | Dormant |
| 00552984 | UNI-TEST INJ 100MG/ML | UNIVET PHARMACEUTICALS LTD. | Solution | TESTOSTERONE PROPIONATE 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 15236 | 2014-02-11 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN) HOLDER |
| 12394 | 2011-06-03 | New Drug Submission (NDS) | Change in ownership |
| 3393 | 2003-10-23 | New Drug Submission (NDS) | |
| 5973 | 1998-06-18 | New Drug Submission (NDS) |
International API supply for TESTOSTERONE PROPIONATE
2 valid EDQM Certificates of Suitability from 2 holders. 3 active FDA Drug Master Files.
Request a quote for SYNOVEX H